[
  {
    "ts": "2025-09-22T17:07:07+00:00",
    "headline": "NHS must pay ‘fair share’, says US drug giant amid Trump pressure",
    "summary": "The NHS must pay more towards new drug development to help cut prices for Americans, a major US pharmaceutical giant has said.",
    "url": "https://uk.finance.yahoo.com/news/nhs-must-pay-fair-share-170707981.html",
    "source": "The Telegraph",
    "provider": "yfinance",
    "raw": {
      "id": "ee661f31-9f27-3af5-948d-812dbf5f9635",
      "content": {
        "id": "ee661f31-9f27-3af5-948d-812dbf5f9635",
        "contentType": "STORY",
        "title": "NHS must pay ‘fair share’, says US drug giant amid Trump pressure",
        "description": "",
        "summary": "The NHS must pay more towards new drug development to help cut prices for Americans, a major US pharmaceutical giant has said.",
        "pubDate": "2025-09-22T17:07:07Z",
        "displayTime": "2025-09-22T17:07:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_telegraph_818/fbd426fa89da620c6feb6b0bd56eec87",
          "originalWidth": 2500,
          "originalHeight": 1567,
          "caption": "Donald Trump",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vqkTj3d9fjmXdNENc17Llg--~B/aD0xNTY3O3c9MjUwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/the_telegraph_818/fbd426fa89da620c6feb6b0bd56eec87.cf.webp",
              "width": 2500,
              "height": 1567,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OEqiA0kdyIP1hvPiRwyFdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_telegraph_818/fbd426fa89da620c6feb6b0bd56eec87.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Telegraph",
          "url": "http://www.telegraph.co.uk/"
        },
        "canonicalUrl": {
          "url": "https://uk.finance.yahoo.com/news/nhs-must-pay-fair-share-170707981.html",
          "site": "finance",
          "region": "GB",
          "lang": "en-GB"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nhs-must-pay-fair-share-170707981.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T14:03:00+00:00",
    "headline": "Bristol Myers Squibb Commits to Veeva Vault CRM",
    "summary": "Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-commits-veeva-140300669.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "bcf897eb-b13f-31f5-9758-c1f5302f9d8e",
      "content": {
        "id": "bcf897eb-b13f-31f5-9758-c1f5302f9d8e",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb Commits to Veeva Vault CRM",
        "description": "",
        "summary": "Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.",
        "pubDate": "2025-09-22T14:03:00Z",
        "displayTime": "2025-09-22T14:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/365dc5fee8d98cd52bb1416af70b45d0",
          "originalWidth": 400,
          "originalHeight": 300,
          "caption": "Veeva Systems (PRNewsfoto/Veeva Systems)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fZEsetrkEsf_N6ne0_dwTA--~B/aD0zMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/365dc5fee8d98cd52bb1416af70b45d0.cf.webp",
              "width": 400,
              "height": 300,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x.pmbh_BEUF1GQUSGcWV5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/365dc5fee8d98cd52bb1416af70b45d0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-commits-veeva-140300669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-commits-veeva-140300669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VEEV"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-22T12:01:00+00:00",
    "headline": "MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug",
    "summary": "The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.",
    "url": "https://www.biopharmadive.com/news/maplight-ipo-cns-schizophrenia-alzheimers-psychosis/760734/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "644b0390-7ed7-3a24-8ce2-1a60c96955b4",
      "content": {
        "id": "644b0390-7ed7-3a24-8ce2-1a60c96955b4",
        "contentType": "STORY",
        "title": "MapLight lines up an IPO in bid to challenge Bristol Myers schizophrenia drug",
        "description": "",
        "summary": "The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.",
        "pubDate": "2025-09-22T12:01:00Z",
        "displayTime": "2025-09-22T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e6729f0eca18e4f277875d33168b7e9d",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "An image from an MRI scan of the brain.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pKAbj5S9C1XXn9Sb383e7w--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e6729f0eca18e4f277875d33168b7e9d.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fkljn0xOjjJL12Li8Dg8ZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e6729f0eca18e4f277875d33168b7e9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/maplight-ipo-cns-schizophrenia-alzheimers-psychosis/760734/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/maplight-lines-ipo-bid-challenge-120100827.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AARD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]